Edition:
United States

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
20 Jul 2018
Change (% chg)

$0.02 (+2.81%)
Prev Close
$0.57
Open
$0.60
Day's High
$0.60
Day's Low
$0.56
Volume
30,148
Avg. Vol
77,123
52-wk High
$2.50
52-wk Low
$0.45

Chart for

About

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company's lead product candidate is Gencaro (bucindolol hydrochloride), a beta-blocker and mild vasodilator that the Company is evaluating in a clinical... (more)

Overall

Beta: 1.81
Market Cap(Mil.): $8.08
Shares Outstanding(Mil.): 13.92
Dividend: --
Yield (%): --

Financials

  ABIO.OQ Industry Sector
P/E (TTM): -- 28.87 33.05
EPS (TTM): -1.53 -- --
ROI: -115.90 13.59 13.17
ROE: -116.10 15.31 15.10

BRIEF-Arca Biopharma Q1 Loss Per Share $0.20

* ARCA BIOPHARMA ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 08 2018

BRIEF-Arca Biopharma And Medtronic Extend Gencaro Clinical Trial Collaboration Agreement

* ARCA BIOPHARMA AND MEDTRONIC EXTEND GENCARO CLINICAL TRIAL COLLABORATION AGREEMENT

Apr 23 2018

BRIEF-ARCA Biopharma Anticipates Meeting With FDA In Q2

* ARCA BIOPHARMA REPORTS TOPLINE PHASE 2B RESULTS FOR GENETIC-AF CLINICAL TRIAL

Feb 26 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $37.33 -0.03
Novartis AG (NOVN.S) CHF82.20 +1.24
Merck & Co., Inc. (MRK.N) $62.52 +0.01
Roche Holding Ltd. (ROG.S) CHF234.00 +2.05
Roche Holding Ltd. (RO.S) CHF238.60 +2.80
Abbott Laboratories (ABT.N) $63.32 -0.46
Bayer AG (BAYGn.DE) €92.05 -0.30
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.36 +0.25
Eli Lilly And Co (LLY.N) $88.47 -0.96

Earnings vs. Estimates